Compostable Medical Supplies in Canada: PLA, PHA and the Road Ahead

August 8, 2026

Canadian healthcare generates a sizable share of the roughly 87,000 tonnes of medical waste the country produces each year, and single-use plastics are a large part of that stream. Gloves, gowns, underpads, and waste bags are designed for one use only, for clinical reasons. The result is a steady, predictable volume of plastic that most provinces still send to landfill or incineration. Sustainability leads, procurement teams, and long-term care operators are asking whether the materials themselves can do more of the work.

This article covers two compostable polymer families — polylactic acid (PLA) and Polyhydroxyalkanoates (PHA) — the compostable supplies available today, and what Canadian policy and infrastructure mean for adoption.

Why Healthcare Generates So Much Plastic Waste

Healthcare depends on single-use plastics because they are inexpensive, reliable, and sterile at the point of use. Infection control protocols favour disposables: a fresh item opened from sealed packaging carries less cross-contamination risk than a reprocessed one, and that logic drives enormous consumption. A single hospital bed produces several kilograms of waste per day, and operating rooms are the most intensive source.

Packaging compounds the problem. Devices arrive wrapped in multiple layers, and supply chains are built around convenience rather than material circularity. Most of the plastics involved are polyethylene, polypropylene, and PVC — durable polymers that persist for decades in landfill. Compostable alternatives cannot replace everything, but they can replace high-volume, low-risk items where contamination is minimal and organic recovery is feasible.

PLA and Polyhydroxyalkanoates: The Basics

PLA, or polylactic acid, is made from fermented plant starch, typically corn or sugarcane. It is the most established compostable bioplastic in commercial use, performing well in film and rigid applications. NatureWorks, a recognized producer of PLA, supplies the Ingeo resin used in food service and healthcare-adjacent products.

Polyhydroxyalkanoates (PHA) are produced by bacterial fermentation of sugars or waste oils; the bacteria store the polymer as energy, and manufacturers harvest it. Danimer Scientific is a notable company commercializing PHA blends. PHA degrades in a wider range of environments, including marine and soil conditions, which makes it attractive for products that may not reach an industrial composter. Blends of PLA and PHA aim to combine PLA's processability with PHA's environmental flexibility.

CliniEco PLA biodegradable waste bag 30 gallon

Compostable Medical Supplies Available Today

A practical range of compostable supplies exists today for non-critical, low-risk use:

Waste bags: PLA liners for general waste and organic streams, including 30-gallon bags sized for healthcare settings.
Underpads: compostable absorbent pads for patient beds, well suited to long-term care where volumes are high and contamination risk is manageable.
Isolation gowns: lightweight PLA gowns for low-acuity tasks such as visitor protection and routine patient contact.

CliniEco carries each category. The PLA biodegradable waste bag handles routine disposal, the compostable underpads support patient care in long-term care homes, and the PLA isolation gown covers non-sterile protection. These are not replacements for sterile surgical textiles; they are entry points where switching is low-risk and measurable.

The Canadian Context: Policy and Compost Infrastructure

Environment and Climate Change Canada has put plastic pollution on the federal agenda, and the Single-use Plastics Prohibition Regulations now cover several consumer items. Provincial governments are moving in parallel: British Columbia and Quebec operate extended producer responsibility rules that treat packaging as a recoverable resource, and more municipalities are weighing organic waste mandates that reach institutional generators.

The gap is composting capacity. Industrial facilities are concentrated in a few regions, and much medical waste still flows through regulated disposal channels that do not accept compostable feedstock. ASTM D6400 certification confirms that a product will disintegrate and biodegrade under industrial conditions; it does not mean a local facility will automatically accept it. Facilities should verify collection options with their waste hauler before committing to a switch.

Honest Limitations and the Near-Term Outlook

Cost remains the first obstacle. Compostable resins cost more than conventional polyethylene, and the premium passes through to procurement budgets. Volume helps: as more facilities standardize on PLA and PHA products, prices trend down. Labelling is the second limitation. In Canada, "compostable" generally means industrial composting, not the backyard bin; home composting of PLA is slow and inconsistent, which is why PHA's tolerance for less controlled conditions matters.

ISO 11607-1 governs packaging for terminally sterilized medical devices, and compostable films are working toward that standard, but certification is a multi-year process. Expect adoption to grow first in non-sterile, high-volume categories.

Timeframe	Likely developments
2026–2027	Wider use of PLA waste bags and underpads in long-term care; more organic waste rules reaching institutions.
2028–2030	PHA blends enter gown and packaging lines; urban composting capacity expands; the cost gap narrows.

The road ahead is not about replacing every plastic in healthcare. It is about targeting high-volume, low-risk items where compostable materials perform reliably, and building the policy and infrastructure to make those choices stick.